2017-07-31T01:08:35+03:00[Europe/Moscow] en true Malabsorption, Traveler's diarrhea, Gastroenteritis, Bile acid malabsorption, Clostridium difficile infection, Steatorrhea, Antibiotic-associated diarrhea, Chronic diarrhea of infancy, Eluxadoline, Radiation enteropathy, Post-vagotomy diarrhea flashcards
Diarrhea

Diarrhea

  • Malabsorption
    Malabsorption is a state arising from abnormality in absorption of food nutrients across the gastrointestinal (GI) tract.
  • Traveler's diarrhea
    Traveler's diarrhea (TD) is a stomach and intestinal infection.
  • Gastroenteritis
    Gastroenteritis, also known as infectious diarrhea, is inflammation of the gastrointestinal tract that involves the stomach and small intestine.
  • Bile acid malabsorption
    Bile acid malabsorption, known also as bile acid diarrhea, is a cause of several gut-related problems, the main one being chronic diarrhea.
  • Clostridium difficile infection
    Clostridium difficile infection (CDI) is a symptomatic infection due to the spore forming bacterium, Clostridium difficile.
  • Steatorrhea
    Steatorrhea (or steatorrhoea) is the presence of excess fat in feces.
  • Antibiotic-associated diarrhea
    Antibiotic-associated diarrhea (AAD) results from an imbalance in the colonic microbiota caused by antibiotic therapy.
  • Chronic diarrhea of infancy
    Chronic diarrhea of infancy, also called toddler's diarrhea, is a common condition typically affecting children between ages 6–30 months, usually resolving by age 4.
  • Eluxadoline
    Eluxadoline (INN, USAN) (brand name Viberzi vye-BER-zee; former developmental code name JNJ-27018966) is an orally-active drug approved for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome (IBS-D).
  • Radiation enteropathy
    Radiation enteropathy or radiation enteritis is a syndrome that may develop following abdominal or pelvic radiation therapy for cancer.
  • Post-vagotomy diarrhea
    Post-vagotomy diarrhea is a form of diarrhea which occurs in 10% of patients after a truncal vagotomy, which can range from severe to debilitating in approximately 2% to 4% of patients.